Danaher Corporation $DHR Holdings Decreased by Applied Finance Capital Management LLC

Applied Finance Capital Management LLC lowered its stake in Danaher Corporation (NYSE:DHRFree Report) by 14.2% in the 3rd quarter, HoldingsChannel.com reports. The firm owned 56,419 shares of the conglomerate’s stock after selling 9,309 shares during the quarter. Applied Finance Capital Management LLC’s holdings in Danaher were worth $11,182,000 at the end of the most recent reporting period.

Several other large investors have also recently bought and sold shares of DHR. Vanguard Group Inc. lifted its position in Danaher by 1.3% in the second quarter. Vanguard Group Inc. now owns 60,769,587 shares of the conglomerate’s stock worth $12,004,424,000 after purchasing an additional 788,499 shares during the period. Geode Capital Management LLC lifted its holdings in shares of Danaher by 0.6% in the second quarter. Geode Capital Management LLC now owns 13,726,194 shares of the conglomerate’s stock valued at $2,697,800,000 after buying an additional 81,670 shares during the period. Norges Bank bought a new position in Danaher during the second quarter valued at about $1,979,503,000. Generation Investment Management LLP boosted its stake in Danaher by 56.2% during the second quarter. Generation Investment Management LLP now owns 4,965,646 shares of the conglomerate’s stock valued at $980,914,000 after buying an additional 1,787,522 shares in the last quarter. Finally, Franklin Resources Inc. grew its holdings in Danaher by 4.0% during the second quarter. Franklin Resources Inc. now owns 4,822,442 shares of the conglomerate’s stock worth $952,625,000 after acquiring an additional 186,357 shares during the period. Institutional investors and hedge funds own 79.05% of the company’s stock.

Analyst Ratings Changes

Several research firms have recently weighed in on DHR. TD Cowen restated a “buy” rating on shares of Danaher in a research report on Wednesday, January 7th. Guggenheim raised their target price on shares of Danaher from $250.00 to $275.00 and gave the stock a “buy” rating in a report on Friday, January 2nd. JPMorgan Chase & Co. upped their price target on Danaher from $270.00 to $275.00 and gave the company an “overweight” rating in a report on Thursday, January 29th. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating on shares of Danaher in a research report on Thursday, January 29th. Finally, Barclays lifted their target price on Danaher from $225.00 to $250.00 and gave the stock an “overweight” rating in a report on Wednesday, October 22nd. Twenty analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat, Danaher has a consensus rating of “Moderate Buy” and an average target price of $253.86.

Check Out Our Latest Report on Danaher

Insider Transactions at Danaher

In related news, SVP Brian W. Ellis sold 21,776 shares of the firm’s stock in a transaction that occurred on Wednesday, November 12th. The shares were sold at an average price of $219.23, for a total transaction of $4,773,952.48. Following the completion of the sale, the senior vice president directly owned 14,553 shares in the company, valued at approximately $3,190,454.19. This trade represents a 59.94% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Teri List sold 3,298 shares of the business’s stock in a transaction that occurred on Tuesday, November 18th. The shares were sold at an average price of $226.50, for a total transaction of $746,997.00. Following the transaction, the director directly owned 20,762 shares in the company, valued at $4,702,593. The trade was a 13.71% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. 11.20% of the stock is owned by corporate insiders.

Danaher Trading Up 0.0%

NYSE DHR opened at $216.65 on Tuesday. The firm’s 50 day moving average price is $229.47 and its two-hundred day moving average price is $215.27. The company has a debt-to-equity ratio of 0.35, a quick ratio of 1.51 and a current ratio of 1.87. Danaher Corporation has a twelve month low of $171.00 and a twelve month high of $242.80. The stock has a market cap of $153.03 billion, a price-to-earnings ratio of 42.99, a PEG ratio of 2.93 and a beta of 0.91.

Danaher (NYSE:DHRGet Free Report) last issued its earnings results on Wednesday, January 28th. The conglomerate reported $2.23 EPS for the quarter, topping the consensus estimate of $2.14 by $0.09. Danaher had a return on equity of 10.81% and a net margin of 14.71%.The business had revenue of $6.84 billion during the quarter, compared to analysts’ expectations of $6.79 billion. During the same quarter last year, the firm posted $2.14 earnings per share. Danaher’s revenue was up 4.6% compared to the same quarter last year. Danaher has set its FY 2026 guidance at 8.350-8.500 EPS. Equities analysts anticipate that Danaher Corporation will post 7.63 EPS for the current year.

Danaher Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, January 30th. Shareholders of record on Friday, December 26th were paid a dividend of $0.32 per share. This represents a $1.28 annualized dividend and a yield of 0.6%. The ex-dividend date of this dividend was Friday, December 26th. Danaher’s payout ratio is 25.40%.

Danaher Profile

(Free Report)

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

Further Reading

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHRFree Report).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.